美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Salspera, Inc.

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：- -

開：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：6,253.87萬

流通股本：566.67萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.1510

淨資產收益率：--

總資產收益率：-58.91%

市淨率：0.00

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Salspera, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://salspera.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Salspera, Inc.最初於2017年6月26日在明尼蘇達州註冊成立為一家有限責任公司，並於2021年11月註冊為特拉華州公司。Salspera, Inc.是一家臨床階段的生物技術公司，致力於開發治療實體瘤的新型療法。這類新型藥物有時被稱為“活體生物製藥”，是經過基因改造的生物製劑，能夠在腫瘤微環境中表達特定的抗腫瘤因子。作為業務的一部分，公司還致力於通過開發其他在研產品來拓展產品線，從而鞏固其在該領域的領先地位。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TKVA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TKVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TKVA\",,,,,undefined,":{"symbol":"TKVA","market":"US","secType":"STK","nameCN":"Salspera, Inc.","latestPrice":0,"timestamp":0,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":5666666,"shares":62538712,"eps":-0.151,"marketStatus":"盤後交易","change":0,"latestTime":"04-29 16:30:51 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.151,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1777507200000},"marketStatusCode":4,"adr":0,"listingDate":1774238400000,"exchange":"NASDAQ","adjPreClose":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TKVA\",,,,,undefined,":{"symbol":"TKVA","floatShares":5666666,"roa":"-58.91%","roe":"--","lyrEps":0,"shares":62538712,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"0.00","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":-0.151,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.151,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TKVA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TKVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TKVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://salspera.com","compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.1224},{"period":"3month","weight":0.0234},{"period":"6month","weight":0.0469},{"period":"1year","weight":0.292},{"period":"ytd","weight":0.0437}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Salspera, Inc.最初於2017年6月26日在明尼蘇達州註冊成立為一家有限責任公司，並於2021年11月註冊為特拉華州公司。Salspera, Inc.是一家臨床階段的生物技術公司，致力於開發治療實體瘤的新型療法。這類新型藥物有時被稱為“活體生物製藥”，是經過基因改造的生物製劑，能夠在腫瘤微環境中表達特定的抗腫瘤因子。作為業務的一部分，公司還致力於通過開發其他在研產品來拓展產品線，從而鞏固其在該領域的領先地位。","exchange":"NASDAQ","name":"Salspera, Inc.","nameEN":"Salspera, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TKVA\",market:\"US\",,,undefined,":null}}